GLIOGENE is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With GLIOGENE, we may be able learn more about possible genes related to this disease -- and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease -- information that one day we hope will lead to improved treatment, as well as preventive strategies.
GLIOGENE is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study. Find out more...
LATEST NEWS AND ANNOUNCEMENTS
MD ANDERSON NEWS
-
Fertility Issues for Parents to Consider before Child's Cancer TreatmentThe best way to preserve your child's fertility during cancer treatment depends on age, sex and if the child has reached puberty. This concern is...
-
Proton Therapy Treatment for Liver CancerProton therapy has several advantages in treating liver cancer over traditional radiation therapy. Since the proton beam is so exact, larger dosages of radiation can...
-
CYCORE - Information Technology Tools Helping With Clinical TrialsCYCORE (Cyberinfrastructure for Comparative Effectiveness Research) was a clinical trial conducted by The University of Texas MD Anderson Cancer Center, University of California-San Diego and...
